The mission of the Pilot and Feasibility Program (P&F) of the Penn DRC is foster the development of new investigators and to provide seed-support for innovative high-risk diabetes-related projects, with an increasing emphasis on clinical and translational science. Over the past 2 funding periods (10 years), the Pilot and Feasibility Program has been highly successful in this regard. 39 investigators received P&F Awards and, of these, 34 (87%) have garnered NIH support, the majority as R01s directly related to their Pilot Awards. During the previous funding period 30 grants were awarded from among 115 applications submitted by investigators representing 22 Departments spanning multiple Schools and Institutes on the campus of the University of Pennsylvania and other Philadelphia institutions. Of the funded grants, nearly 80% were to new investigators and more than 25% were dedicated to clinical and translational projects. During the next funding period we propose to continue the core mission of the Pilot and Feasibility Program. Given the past successes of the program, the increased cost of performing research in the setting of a more competitive general funding environment, and the clear need based on the escalating numbers of applications from new and established investigators both within and outside of the diabetes research community, we feel that this program continues to be well justified. We also propose to administer one additional Pilot and Feasibility Award dedicated to the use of the exciting new Regional Metabolomics Core at Princeton University that is proposed in this application and consistent with the P&F mission.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK019525-36
Application #
8310463
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J1))
Project Start
Project End
Budget Start
2012-05-15
Budget End
2013-03-31
Support Year
36
Fiscal Year
2012
Total Cost
$370,000
Indirect Cost
$120,000
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Brown, Justin C; Troxel, Andrea B; Ky, Bonnie et al. (2016) A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results. Contemp Clin Trials 47:366-75
Zhang, Yuxiang; Fang, Bin; Damle, Manashree et al. (2016) HNF6 and Rev-erbα integrate hepatic lipid metabolism by overlapping and distinct transcriptional mechanisms. Genes Dev 30:1636-44
Titchenell, Paul M; Quinn, William J; Lu, Mingjian et al. (2016) Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab 23:1154-66
Ackermann, Amanda M; Wang, Zhiping; Schug, Jonathan et al. (2016) Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol Metab 5:233-44
Henley, Kathryn D; Stanescu, Diana E; Kropp, Peter A et al. (2016) Threshold-Dependent Cooperativity of Pdx1 and Oc1 in Pancreatic Progenitors Establishes Competency for Endocrine Differentiation and β-Cell Function. Cell Rep 15:2637-50
Tsai, Yu-Cheng; Cooke, Nancy E; Liebhaber, Stephen A (2016) Long-range looping of a locus control region drives tissue-specific chromatin packing within a multigene cluster. Nucleic Acids Res 44:4651-64
Wang, Yue J; Schug, Jonathan; Won, Kyoung-Jae et al. (2016) Single-Cell Transcriptomics of the Human Endocrine Pancreas. Diabetes 65:3028-38
Tomar, Dhanendra; Dong, Zhiwei; Shanmughapriya, Santhanam et al. (2016) MCUR1 Is a Scaffold Factor for the MCU Complex Function and Promotes Mitochondrial Bioenergetics. Cell Rep 15:1673-85
Wang, Yi; Frank, David B; Morley, Michael P et al. (2016) HDAC3-Dependent Epigenetic Pathway Controls Lung Alveolar Epithelial Cell Remodeling and Spreading via miR-17-92 and TGF-β Signaling Regulation. Dev Cell 36:303-15
Shearin, Abigail L; Monks, Bobby R; Seale, Patrick et al. (2016) Lack of AKT in adipocytes causes severe lipodystrophy. Mol Metab 5:472-9

Showing the most recent 10 out of 624 publications